Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Aoki

Showing results (131-140 of 147) with videos related to

Pageof 15
Sort By:
Leukemia & Lymphoma|July 29, 2017
Effect of cytogenetic risk status on outcomes for patients with acute myeloid leukemia undergoing various types of allogeneic hematopoietic cell transplantation: an analysis of 7812 patientsMasamitsu Yanada, Jinichi Mori, Jun Aoki, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 20, 2015
Effect of Granulocyte Colony-Stimulating Factor-Combined Conditioning in Cord Blood Transplantation for Myelodysplastic Syndrome and Secondary Acute Myeloid Leukemia: A Retrospective Study in JapanTakaaki Konuma, Satoshi Takahashi, Naoyuki Uchida, et al.
Bone Marrow Transplantation|May 16, 2021
Allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome in adolescent and young adult patientsYoshimitsu Shimomura, Masahiko Hara, Takaaki Konuma, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 2, 2014
[A case of cecum colon cancer with lymph node metastasis successfully treated with XELOX plus bevacizumab]Shingo Ito, Ryosuke Ichikawa, Kazumasa Kure, et al.
International Journal of Hematology|January 4, 2021
Effect of donor type on volume of blood transfusions required after allogeneic hematopoietic cell transplantationSaiko Kurosawa, Takuhiro Yamaguchi, Saori Nakabayashi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2017
Prognostic Impact of Donor Source on Allogeneic Hematopoietic Stem Cell Transplantation Outcomes in Adults with Chronic Myelomonocytic Leukemia: A Nationwide Retrospective Analysis in JapanHidehiro Itonaga, Kazunari Aoki, Jun Aoki, et al.
Annals of Hematology|November 14, 2016
Role of reduced-intensity conditioning allogeneic hematopoietic cell transplantation in older patients with de novo acute myeloid leukemiaSatoshi Yamasaki, Akihiro Hirakawa, Jun Aoki, et al.
Bone Marrow Transplantation|May 8, 2021
Low-dose antithymocyte globulin inhibits chronic graft-versus-host disease in peripheral blood stem cell transplantation from unrelated donorsSouichi Shiratori, Junichi Sugita, Shigeo Fuji, et al.
Bone Marrow Transplantation|May 7, 2024
Prognostic impact of the conditioning intensity on outcomes after allogeneic transplantation for MDS with low blasts: a nationwide retrospective study by the adult MDS working group of the Japan Society for Transplantation and Cellular TherapyHidehiro Itonaga, Yasushi Miyazaki, Machiko Fujioka, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 23, 2020
Outcome and Risk Factors for Therapy-Related Myeloid Neoplasms Treated with Allogeneic Stem Cell Transplantation in JapanMichiko Kida, Kensuke Usuki, Naoyuki Uchida, et al.
Pageof 15

Showing results (131-140 of 147) with videos related to

Sort By:
Pageof 15
Leukemia & Lymphoma|July 29, 2017
Effect of cytogenetic risk status on outcomes for patients with acute myeloid leukemia undergoing various types of allogeneic hematopoietic cell transplantation: an analysis of 7812 patientsMasamitsu Yanada, Jinichi Mori, Jun Aoki, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 20, 2015
Effect of Granulocyte Colony-Stimulating Factor-Combined Conditioning in Cord Blood Transplantation for Myelodysplastic Syndrome and Secondary Acute Myeloid Leukemia: A Retrospective Study in JapanTakaaki Konuma, Satoshi Takahashi, Naoyuki Uchida, et al.
Bone Marrow Transplantation|May 16, 2021
Allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome in adolescent and young adult patientsYoshimitsu Shimomura, Masahiko Hara, Takaaki Konuma, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 2, 2014
[A case of cecum colon cancer with lymph node metastasis successfully treated with XELOX plus bevacizumab]Shingo Ito, Ryosuke Ichikawa, Kazumasa Kure, et al.
International Journal of Hematology|January 4, 2021
Effect of donor type on volume of blood transfusions required after allogeneic hematopoietic cell transplantationSaiko Kurosawa, Takuhiro Yamaguchi, Saori Nakabayashi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2017
Prognostic Impact of Donor Source on Allogeneic Hematopoietic Stem Cell Transplantation Outcomes in Adults with Chronic Myelomonocytic Leukemia: A Nationwide Retrospective Analysis in JapanHidehiro Itonaga, Kazunari Aoki, Jun Aoki, et al.
Annals of Hematology|November 14, 2016
Role of reduced-intensity conditioning allogeneic hematopoietic cell transplantation in older patients with de novo acute myeloid leukemiaSatoshi Yamasaki, Akihiro Hirakawa, Jun Aoki, et al.
Bone Marrow Transplantation|May 8, 2021
Low-dose antithymocyte globulin inhibits chronic graft-versus-host disease in peripheral blood stem cell transplantation from unrelated donorsSouichi Shiratori, Junichi Sugita, Shigeo Fuji, et al.
Bone Marrow Transplantation|May 7, 2024
Prognostic impact of the conditioning intensity on outcomes after allogeneic transplantation for MDS with low blasts: a nationwide retrospective study by the adult MDS working group of the Japan Society for Transplantation and Cellular TherapyHidehiro Itonaga, Yasushi Miyazaki, Machiko Fujioka, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 23, 2020
Outcome and Risk Factors for Therapy-Related Myeloid Neoplasms Treated with Allogeneic Stem Cell Transplantation in JapanMichiko Kida, Kensuke Usuki, Naoyuki Uchida, et al.
Pageof 15